1. Home
  2. LSTA vs PCLA Comparison

LSTA vs PCLA Comparison

Compare LSTA & PCLA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Lisata Therapeutics Inc.

LSTA

Lisata Therapeutics Inc.

HOLD

Current Price

$2.02

Market Cap

20.9M

Sector

Health Care

ML Signal

HOLD

Logo PicoCELA Inc. American Depositary Shares

PCLA

PicoCELA Inc. American Depositary Shares

HOLD

Current Price

$0.14

Market Cap

18.6M

ML Signal

HOLD

Company Overview

Basic Information
Metric
LSTA
PCLA
Founded
1980
2008
Country
United States
Japan
Employees
N/A
N/A
Industry
Misc Health and Biotechnology Services
Building Products
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
20.9M
18.6M
IPO Year
N/A
2025

Fundamental Metrics

Financial Performance
Metric
LSTA
PCLA
Price
$2.02
$0.14
Analyst Decision
Strong Buy
Analyst Count
2
0
Target Price
$23.50
N/A
AVG Volume (30 Days)
23.4K
207.3K
Earning Date
11-06-2025
02-13-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$1,070,000.00
$5,065,197.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
5.26
52 Week Low
$1.81
$0.14
52 Week High
$4.20
$9.80

Technical Indicators

Market Signals
Indicator
LSTA
PCLA
Relative Strength Index (RSI) 45.08 14.91
Support Level $1.97 $0.27
Resistance Level $2.15 $0.33
Average True Range (ATR) 0.12 0.03
MACD 0.02 -0.01
Stochastic Oscillator 51.87 8.59

Price Performance

Historical Comparison
LSTA
PCLA

About LSTA Lisata Therapeutics Inc.

Lisata Therapeutics Inc is a clinical-stage pharmaceutical company dedicated to the discovery, development, and commercialization of therapies for the treatment of solid tumors and other diseases. Its investigational product, certepetide, is designed to activate a novel uptake pathway that allows co-administered or tethered (i.e., molecularly bound) anti-cancer drugs to target and penetrate solid tumors more effectively. The group has one operating segment, the research and development of its investigational drug product.

About PCLA PicoCELA Inc. American Depositary Shares

PicoCELA Inc specializes in manufacturing, installing, and servicing enterprise wireless mesh solutions. The company generates revenue from two main sources: product equipment sales, and Software as a Service (SaaS) and maintenance services. The company develops the PCWL series of mesh Wi-Fi access points, which utilize its proprietary PicoCELA Backhaul Engine (PBE) technology to enable wireless communication. The company outsources manufacturing and sells these devices directly to customers through distributors. Additionally, the company offers a cloud portal service in a SaaS model, allowing users to monitor connectivity and traffic at their access points. This platform also supports the installation of proprietary edge-computing software into the devices.

Share on Social Networks: